User:Adjarock/Faricimab/Daspj Peer Review

General info

 * Whose work are you reviewing?

Adjarock


 * Link to draft you're reviewing
 * N/A
 * Link to the current version of the article (if it exists)
 * Faricimab
 * Faricimab

Evaluate the drafted changes
Lead:

- Very well written, covers the main points and doesn't include extraneous details. When I read it, I feel like I have a great summary of what the article is about

Article:

- Especially great job of clearly explaining out medical jargon and providing link outs where appropriate. Adding images will probably be a challenge with such a new drug, so understandable that there are none there. It may also be helpful to expand upon the pharmacology section, going into further detail of the pathways involved.

References:

- On clicking some of the references, they all seem to be appropriate. May need caution with using investor reports from Roche as those could be considered biased sources.

Edits:

- As mentioned above, could consider adding more detail to the pharmacology section. Otherwise, all additions to the article are well-placed and add significant value.

Overall:

- The edits made to this article have been fantastic thus far. Most of the important areas have been expanded upon and the necessary information is included. I had no idea about this drug prior to reading this article, and I now feel I have a solid basis of understanding. As more information comes out on this drug, it will be interesting to see how the information changes. The main area where future efforts could be focused on include expanding the pharmacology section. Excellent job.